Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05028101 · ClinicalTrials.gov registry record · NA
The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction
A NA study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT05028101: Clinical Trial NA study, sponsored by Case Comprehensive Cancer Center.
NCT05028101 is a NA study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05028101, a NA study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study will examine if a functional medicine approach, delivered as an adjunct to standard of care, is feasible, safe, clinically beneficial and cost-effective for patients undergoing autologous breast reconstruction.
Primary Outcome
Success will be defined as enrolling and randomizing 25% or more of those screened per arm.
Interventions
- PROCEDURE Delayed autologous breast reconstruction
- BEHAVIORAL Perioperative Functional Medicine (FM) Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-02-20 |
| Est. Completion | 2024-06-06 |
| Phase | NA |
Why NCT05028101 stopped before completion
NCT05028101 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Delayed autologous breast reconstruction is the first listed.
NCT05028101 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05028101 about?
NCT05028101 is a clinical study titled "The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction". This study will examine if a functional medicine approach, delivered as an adjunct to standard of care, is feasible, safe, clinically beneficial and cost-effective for patients undergoing autologous breast reconstruction.
What is the current status of trial NCT05028101?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2023-02-20. Estimated completion is 2024-06-06.
What interventions are being tested in trial NCT05028101?
The interventions under investigation include: Delayed autologous breast reconstruction (PROCEDURE), Perioperative Functional Medicine (FM) Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT05028101?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05028101's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI